ActiveGRANT

DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

Department of DefenseDept. of the Army -- USAMRAA

AI Overview

This DoD funding supports patient-centered research to improve lung cancer outcomes and survivorship experiences. Projects must include patient/survivor advocates and can pursue translational or clinical research, including pilot trials.

This summary is AI-generated from the official solicitation.

Key Details

Agency
Department of Defense
Funding Amount
—
Release Date
May 5, 2026
Due Date
September 2, 2026

Official Description

<p><strong>Summary: </strong>The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.</p><p><br></p><p><strong>Distinctive Features:</strong></p><p>• ...
View on official source

Change History

Field UpdatedMay 6, 2026 at 6:47 PM

DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

Minor editorial changes. The prefix "DoW" was added to the title, likely indicating Department of War or a similar organizational designation, with no change to the program's substantive scope or requirements.

Opportunity AddedMay 5, 2026 at 7:46 PM

Lung Cancer Patient-Centered Outcomes and Survivorship Award

New Grants.gov opportunity: Lung Cancer Patient-Centered Outcomes and Survivorship Award

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial